Vertex Pharmaceuticals Incorporated (VRTX)


Vertex Pharmaceuticals Incorporated (VRTX)

$179.00 USD

2.86 (1.62%)

Updated Sep 20 12:43pm

Add VRTX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 329 in Biotech

See all “A” rated Strong Buy stocks

VRTX Daily Price Range
VRTX 52-Week Price Range

VRTX Stock Chart More Charts


VRTX Price/Volume Stats

Current price $179.00
Prev. close $176.14
Day low $175.58
Day high $179.55
50-day MA $177.29
200-day MA $177.91
52-week high $195.81
52-week low $151.80
Volume 736,285
Avg. volume 1,283,095
Dividend yield N/A
Market Cap 46.01B

Vertex Pharmaceuticals Incorporated (VRTX) Company Bio


Vertex Pharmaceuticals engages in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets. The company focuses on developing and commercializing therapies for the treatment of cystic fibrosis (CF); and advancing its research and early-stage development programs. The company was founded in 1989 and is based in Boston, Massachusetts.





VRTX News Stream


Event/Time News Detail
Loading, please wait...

VRTX Social Stream


Loading social stream, please wait...

View Full VRTX Social Stream

VRTX Returns

1-mo -3.97%
3-mo -2.70%
6-mo -1.39%
1-year -0.84%
3-year 95.22%
5-year 72.53%
YTD 8.02%
2018 10.58%
2017 103.42%
2016 -41.45%
2015 5.92%
2014 59.89%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.4694 seconds.